“Media reviews describe it as a loophole,” says Alliance for Pharmacy Compounding CEO Scott Brunner. “It’s not a loophole. It’s extremely intentional plan.” Brunner has expressed irritation about how some protection of the rise of compounding GLP-1s conflates unlicensed pharmacies peddling copyright medications or research peptides with credentialed functions https://jaschav196suv7.wiki-promo.com/user